Table 1

Cell survival (LDH absorbance) of different cell lines after infection with B. henselae

Cell lineUninfected (SD)Infected (SD)P, t test
HUVECSerum +0.36 (0.04)0.42 (0.06)0.57
Serum −0.14 (0.02)0.27 (0.04)2E-5
Actino D0.11 (0.02)0.21 (0.02)1E-5
Human dermal microvascular endothelialSerum +0.24 (0.01)0.27 (0.03)0.04
Serum −0.19 (0.01)0.23 (0.02)0.001
Actino D0.19 (0.02)0.24 (0.02)0.002
MRC-5Serum +0.66 (0.04)0.73 (0.06)0.68
Serum −0.50 (0.07)0.54 (0.04)0.78
Actino D0.61 (0.05)0.63 (0.03)0.93
WI-38Serum +0.51 (0.03)0.47 (0.03)0.78
Serum −0.36 (0.02)0.38 (0.03)0.77
Actino D0.45 (0.06)0.50 (0.03)0.67
HELSerum +1.09 (0.05)1.14 (0.04)0.14
Serum −0.67 (0.07)0.63 (0.03)0.38
Actino D0.86 (0.05)0.91 (0.04)0.13
A549Serum +1.03 (0.12)1.14 (0.08)0.17
Serum −0.97 (0.08)0.93 (0.09)0.61
Actino D0.92 (0.07)0.92 (0.02)0.92
Modin–Darby canine kidneySerum +0.82 (0.04)0.80 (0.07)0.6
Serum −0.80 (0.03)0.76 (0.07)0.35
Actino D0.21 (0.02)0.24 (0.05)0.34
Hep-2Serum +1.65 (0.07)1.67 (0.12)0.8
Serum −1.54 (0.06)1.51 (0.09)0.65
Actino D1.51 (0.03)1.55 (0.07)0.29
RDSerum +1.24 (0.07)1.03 (0.21)0.11
Serum −0.89 (0.04)0.86 (0.05)0.38
Actino D0.39 (0.07)0.46 (0.04)0.13